AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $4.24M in the quarter ending March 31, 2025, a decrease of -57.45%. This brings the company's revenue in the last twelve months to $23.11M, down -35.41% year-over-year. In the year 2024, AbCellera Biologics had annual revenue of $28.83M, down -24.17%.

• Revenue (ttm): $23.11M
• Revenue Growth: -35.41%
• P/S Ratio: 26.85
• Revenue / Employee: $38,782
• Employees: 596
• Market Cap: 625.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.